logo Fabry logo

Program

5th Update on Fabry Nephropathy:

Biomarkers, Progression and Treatment Opportunities

April 25-27, 2017 Mexico City, Mexico

An Official Satellite of the ISN WORLD CONGRESS OF NEPHROLOGY WCN2017.ORG

Supporting OrganizationKidneys for Life SecretariatCONGREX.COM.PA

Meeting Co-Chairs

  • Ricardo Correa-Rotter, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán and National Autonomous University of México, Mexico City
  • Derralyn Hughes, Royal Free London NHS Foundation Trust University College London, London, UK
  • Luiz Antonio Ribeiro Moura, Escola Paulista de Medicina - Federal University of Sao Paulo, Brazil
  • Gregorio T. Obrador Vera, Universidad Panamericana School of Medicine, Mexico City, Mexico
  • Juan M. Politei, Fundación Para El Estudio De Las Enfermedades Neurometabólicas, Buenos Aires, Argentina
  • Raphael Schiffmann, Baylor Research Institute, Dallas, Texas USA
  • Hernán Trimarchi, Hospital Britanico de Buenos Aires, Buenos Aires, Argentina
  • Stephen Waldek, University of Sunderland, Sunderland UK
  • Christoph Wanner, University of Würzburg, Würzburg Germany
  • David G. Warnock, University of Alabama at Birmingham, Birmingham, AL USA
  • Michael West, QE II Health Sciences Centre Dalhousie University, Halifax, Nova Scotia, Canada

 

This educational activity is supported by independent medical educational grants from Protalix Biotherapeutics, Actelion Pharmaceuticals Ltd, Amicus Therapeutics, and Sanofi Genzyme.

2017 Program (Confirmed Participants) CLICK HERE